CytomX Therapeutics, Inc

(NASDAQ:CTMX)

Latest On CytomX Therapeutics, Inc (CTMX):

Date/Time Type Description Signal Details
2023-05-10 01:40 ESTNewsCytomX GAAP EPS of -$0.05 beats by $0.06, revenue of $23.5M beats by $3.59MN/A
2023-05-10 01:40 ESTNewsCytomX Therapeutics, Inc. (CTMX) Q1 2023 Earnings Call TranscriptN/A
2023-05-08 22:39 ESTNewsCytomX Q1 2023 Earnings PreviewN/A
2023-03-28 20:35 ESTNewsCytomX slumps ~15% amid FY22 miss, AbbVie pulls plug on CX-2029 studiesN/A
2023-03-28 05:02 ESTNewsCytomX GAAP EPS of -$1.51 misses by $0.24, revenue of $53.16M misses by $18.91MN/A
2023-03-28 05:02 ESTNewsCytomX Therapeutics, Inc. (CTMX) Q4 2022 Earnings Call TranscriptN/A
2023-03-26 22:50 ESTNewsCytomX Q4 2022 Earnings PreviewN/A
2023-01-26 19:27 ESTNewsCytomX stock rises as Astellas to pay $5M milestone under research pactN/A
2023-01-20 16:52 ESTNewsCytomX Therapeutics (CTMX) Presents at the 41st Annual J.P. Morgan Healthcare Conference - SlideshowN/A
2023-01-05 21:53 ESTNewsCytomX shares soar +50% on collaboration with Moderna to make mRNA-based therapies (update)N/A
2022-11-17 19:43 ESTNewsCytomX surges 26% on license deal with Regeneron to develop cancer drugsN/A
2022-11-09 04:24 ESTNewsCytomX GAAP EPS of -$0.35 misses by $0.05, revenue of $16.92M misses by $3.13MN/A
2022-11-09 04:24 ESTNewsCytomX Therapeutics, Inc. (CTMX) Q3 2022 Earnings Call TranscriptN/A
2022-11-08 10:31 ESTNewsCytomX Q3 2022 Earnings PreviewN/A
2022-08-06 08:07 ESTNewsCytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-05 01:24 ESTNewsCytomX GAAP EPS of -$0.37 misses by $0.02, revenue of $18.17M misses by $0.21MN/A
2022-08-03 19:17 ESTNewsCytomX Q2 2022 Earnings PreviewN/A
2022-07-14 04:42 ESTNewsCytomX Therapeutics to cut workforce by about 40%N/A
2022-07-07 11:13 ESTNewsCytomX downgraded at several Street firms following breast cancer therapy resultsN/A
2022-07-06 20:52 ESTNewsCytomX shares plummet 28% on phase 2 study of breast cancer antibody praluzatamabN/A
2022-06-25 00:13 ESTNewsCytomX stock rises after BMO Capital starts with Outperform ratingN/A
2022-05-26 10:06 ESTNewsCytomX begins dosing in early-stage study of CX-904 for advanced solid tumorsN/A
2022-05-07 18:59 ESTNewsCytomX Therapeutics' (CTMX) CEO Sean McCarthy on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-06 01:39 ESTNewsCytomX GAAP EPS of -$0.37 misses by $0.01, revenue of $17.13M misses by $4.12MN/A
2022-05-05 01:52 ESTNewsCytomX Q1 2022 Earnings PreviewN/A
2022-03-04 21:13 ESTNewsCytomX Therapeutics, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-02 15:41 ESTNewsCytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-02 15:41 ESTNewsCytomX stock soars 16% as Q4 revenue rises 20% Y/YN/A
2022-03-01 23:24 ESTNewsCytomX GAAP EPS of -$1.30 misses by $0.13, revenue of $69.57M misses by $5.85MN/A
2022-01-20 02:47 ESTNewsCytomX rises 7% on FDA nod for phase 1 trial of CX-904 to treat solid tumorsN/A
2021-12-21 00:44 ESTNewsCytomX Therapeutics falls 28% on interim mid-stage results on cancer candidateN/A
2021-12-15 08:40 ESTNewsCytomX: Pullbacks Are OpportunitiesN/A
2021-11-07 12:12 ESTNewsCytomX Therapeutics, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-07 12:12 ESTNewsCytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-05 03:59 ESTNewsCytomX EPS beats by $0.65, misses on revenueN/A
2021-11-04 06:53 ESTNewsCytomX Q3 2021 Earnings PreviewN/A
2021-09-21 15:32 ESTNewsCytomX: Solving A Critical Problem In The High-Value ADC SpaceN/A
2021-08-14 08:14 ESTNewsCytomX Therapeutics (CTMX) Investor Presentation - SlideshowN/A
2021-08-08 10:40 ESTNewsCytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-06 00:59 ESTNewsCytomX EPS in-line, misses on revenueN/A
2021-07-21 03:19 ESTNewsIterum keeps rising even as RBC analyst cautions, Premier hurt by Barclays’ double downgrade; and more in today’s analyst actionN/A
2021-07-21 03:05 ESTNewsChecking In On CytomX TherapeuticsN/A
2021-05-07 06:27 ESTNewsCytomX EPS beats by $0.06, misses on revenueN/A
2021-02-26 03:27 ESTFinancialsCompany financials have been released.Neutral
2021-02-25 03:28 ESTEarnings EstimateAn EPS average of -$2.27 is estimated for the 2022 year.Sell
2021-02-25 03:28 ESTEarnings EstimateAn EPS average of -$0.41 is estimated for the quarter ending on June 30, 2021.Sell
2021-02-25 00:47 ESTNewsCytomX beats on revenueN/A
2021-02-25 00:47 ESTNewsCytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q4 2020 Results - Earnings Call TranscriptN/A
2021-01-21 07:47 ESTNewsCytomX Therapeutics secures $100M capital raiseN/A
2021-01-20 01:57 ESTNewsCytomX Therapeutics -3% AH, proposes public offeringN/A

About CytomX Therapeutics, Inc (CTMX):

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatment of squamous non-small cell lung cancer, head and neck squamous cell carcinoma, esophageal and gastro-esophageal junction cancers, and diffuse large B-cell lymphoma; BMS-986249, a CTLA-4 Probody therapeutic drug, which is in Phase I/II clinical trials for the treatment of metastatic melanoma; and BMS-986288, an anti-CTLA-4 Probody drug, which is in Phase I clinical trials for the treatment of solid tumors. It also develops CX-2043, a conditionally activated ADC targeting the epithelial cell adhesion molecule, as well as CX-904, a conditionally activated epidermal growth factor receptor for the treatment of solid tumor. The company has strategic collaborations with AbbVie Ireland Unlimited Company, Amgen, Inc., Bristol-Myers Squibb Company, ImmunoGen, Inc., Pfizer Inc., and Astellas Pharma Inc. to develop Probody therapeutics. CytomX Therapeutics, Inc. was founded in 2008 and is headquartered in South San Francisco, California.

CTMX Quotes by TradingView

See Advanced Chart

General

  • Name CytomX Therapeutics, Inc
  • Symbol CTMX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 144
  • Fiscal Year EndDecember
  • IPO Date2015-10-08
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.cytomx.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 3.89
  • Price/Book (Most Recent Quarter) 11
  • Enterprise Value Revenue 2.56
  • Enterprise Value EBITDA 0.14
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.57
  • Next Year EPS Estimate -$1.95
  • Next Quarter EPS Estimate -$0.38
  • Profit Margin -33%
  • Operating Margin -48%
  • Return on Assets -9%
  • Return on Equity -65%
  • Revenue 100.36 million
  • Earnings Per Share -$2.20
  • Revenue Per Share $2.18
  • Gross Profit 100.36 million
  • Quarterly Earnings Growth 97.8%
View More

Highlights

  • Market Capitalization 520.87 million
  • EBITDA -94456000
  • PE Ratio -523.31
  • PEG Ratio -1.8
  • Analyst Target Price $12.56
  • Book Value Per Share $1.03
View More

Share Statistics

  • Shares Outstanding 64.78 million
  • Shares Float 54.81 million
  • % Held by Insiders 289%
  • % Held by Institutions 83.5%
  • Shares Short 3.33 million
  • Shares Short Prior Month 3.33 million
  • Short Ratio 3.15
  • Short % of Float 5%
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.61
  • 52 Week High $15.44
  • 52 Week Low $4.66
  • 50 Day Moving Average 8.18
  • 200 Day Moving Average 7.39
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

CytomX Therapeutics, Inc (CTMX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

CytomX Therapeutics, Inc (CTMX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$N/A-$0.31-$0.5038.49%
2020-09-302020-11-05$N/A-$0.32-$0.4325.29%
2020-06-302020-08-06$N/A-$0.34$0.49-169.86%
2020-03-312020-05-07$49.59 million$0.26-$0.40164.53%
2019-12-312020-02-27$8.28 million-$0.79-$0.49-61.22%
2019-09-302019-11-07$10.71 million-$0.52-$0.52-0.56%
2019-06-302019-08-07$9.01 million-$0.64-$0.54-19.25%
2019-03-312019-05-09$29.49 million-$0.31-$0.5543.38%
2018-12-312019-02-27$11.47 million-$0.74-$0.43-70.39%
2018-09-302018-11-06$12.51 million-$0.53-$0.44-19.56%
2018-06-302018-08-08$21.34 million-$0.35-$0.4419.54%
2018-03-312018-05-09$14.18 million-$0.40-$0.34-16.18%
2017-12-312018-03-07$27.07 million$0.03-$0.29110.49%
2017-09-302017-11-07$24.15 million-$0.28-$0.319.68%
2017-06-302017-08-07$8.75 million-$0.69-$0.37-87.5%
2017-03-312017-05-05$11.65 million-$0.23-$0.4447.49%
2016-12-312017-03-02$6.27 million-$0.39-$0.426.59%
2016-09-302016-11-03$3.45 million-$0.40-$0.31-30.42%
2016-06-302016-08-03$3.09 million-$0.39-$0.4614.6%
2016-03-312016-05-06$2.22 million-$0.44-$0.26-72.55%
2015-12-312016-03-07$1.99 million-$0.39-$0.34-14.71%
2015-09-302015-10-14$1.94 million-$14.26-$0.25-5604%

CytomX Therapeutics, Inc (CTMX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A N/A N/A 42.81 million 36.44 million
Income Before Tax N/A N/A N/A -1.71 million -35.88 million
Selling General Administrative N/A N/A N/A 9.57 million 9.22 million
Gross Profit N/A N/A N/A N/A 8.28 million
Ebit N/A N/A N/A -2.16 million -37.38 million
Operating Income N/A N/A N/A -2.79 million -37.38 million
Income Tax Expense N/A N/A N/A -13.91 million -421000
Total Revenue N/A N/A N/A 49.59 million 8.28 million
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A N/A 12000 1.5 million
Net Income From Continuing Operations N/A N/A N/A 12.21 million -35.46 million
Net Income Applicable to Common Shares -14.7 million -14.71 million -15.68 million 12.21 million -35.46 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A N/A 53.56 million 39.14 million
Change to Liabilities -18.1 million -15.88 million 80.47 million -9.09 million -10.56 million
Total Cash Flow from Investing Activities -90.07 million 49.45 million 2.44 million 52.86 million 38.51 million
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A N/A 401000 63000
Change to Operating Activities 4 million -5.1 million -16.94 million 10.62 million -3.53 million
Change in Cash N/A N/A N/A 23.78 million 15.25 million
Total Cash from Operating Activities -24.68 million 97.1 million -49.74 million -29.48 million -23.32 million
Depreciation N/A N/A N/A 608000 677000
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A -6000 10 million
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income 3.81 million 3.33 million 3.89 million 3.85 million 3.79 million
Capital Expenditures N/A N/A N/A 703000 628000
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A N/A N/A 366.9 million 290.17 million
Total Stockholder Equity N/A N/A N/A 69.77 million 51.11 million
Other Current Liabilities 74.87 million 74.45 million N/A N/A 51.38 million
Total Assets N/A N/A N/A 436.66 million 341.28 million
Common Stock 1000 1000 1000 1000 1000
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -450.12 million -435.41 million -420.7 million -405.03 million -417.23 million
Other Liabilities 186.26 million 202.56 million 221.54 million 236.79 million 179.71 million
Other Assets 3.09 million 2.3 million 2.3 million 2.3 million 2.93 million
Cash N/A N/A N/A 143.29 million 188.43 million
Total Current Liabilities 100.92 million 102.03 million N/A 106 million 85.59 million
Other Stockholder Equity -47000 -47000 16000 336000 57000
Property, Plant & Equipment 29.45 million 30.43 million 31.43 million 32.08 million 32.75 million
Total Current Assets 324.01 million 340.31 million N/A 400.07 million 303.34 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 47.69 million 45.91 million 56.64 million 67.54 million 48.85 million
Short Term Investments N/A N/A N/A 104.64 million 107.72 million
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 3 million 3.64 million N/A 3.78 million 4.16 million

CytomX Therapeutics, Inc (CTMX) Chart:

CytomX Therapeutics, Inc (CTMX) News:

Below you will find a list of latest news for CytomX Therapeutics, Inc (CTMX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

CytomX Therapeutics, Inc (CTMX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.52.3CALL92 1664524.32TRUE-0.15-0.06
2024-05-1750.75CALL771 6818399.49FALSE-0.3-0.29
2024-05-177.50.45CALL773 2175407.63FALSE-0.1-0.18
2024-05-17100.2CALL834 850392.5FALSE-0.1-0.33
2024-05-172.50.35PUT1810 2729427.43FALSE0.10.4
2024-05-1751.5PUT95 473382.59TRUE-0.05-0.03
2024-05-177.53.2PUT1 53231.07TRUE0.10.03
2024-05-17105.8PUT0 10650.26TRUE00
2024-06-212.51.9CALL1 59387.64TRUE-0.5-0.21
2024-06-2151.1CALL188 15207216.04FALSE-0.03-0.03
2024-06-217.50.65CALL0 104213.33FALSE00
2024-06-21100.4CALL1 303228.47FALSE0.010.03
2024-06-212.50.4PUT30 349240.8FALSE0.050.14
2024-06-2151.7PUT8 293216.03TRUE00
2024-06-217.53.7PUT2 21219.45TRUE-0.1-0.03
2024-06-21105.9PUT0 1241.93TRUE00
2024-07-192.50CALL0 0276.42TRUE00
2024-07-1951.4CALL0 4328.88FALSE00
2024-07-197.50.75CALL0 100FALSE00
2024-07-19100CALL0 0166.83FALSE00
2024-07-192.50.15PUT2 0126.58FALSE0.150
2024-07-1952PUT0 1238.79TRUE00
2024-07-197.50PUT0 0291.93TRUE00
2024-07-19100PUT0 0228.79TRUE00
2024-08-162.52.5CALL0 362419.18TRUE00
2024-08-1651.32CALL0 148140.07FALSE00
2024-08-167.50.85CALL15 6172.23FALSE0.850
2024-08-16100CALL0 00FALSE00
2024-08-162.50.4PUT0 56167.14FALSE00
2024-08-1650PUT0 0124.62TRUE00
2024-08-167.50PUT0 0170.39TRUE00
2024-08-16100PUT0 0319.78TRUE00
2024-11-152.52.3CALL10 44113.87TRUE-0.4-0.15
2024-11-1551.38CALL2 96125.08FALSE-0.12-0.08
2024-11-157.51.05CALL0 24196.17FALSE00
2024-11-15100CALL0 0219.83FALSE00
2024-11-152.50.7PUT0 81126.55FALSE00
2024-11-1550PUT0 0194.96TRUE00
2024-11-157.54PUT0 75234.02TRUE00
2024-11-15100PUT0 0197.37TRUE00
2032-10-2150.05CALL1 60FALSE00

Latest CTMX Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST4$1.75
Jun 13, 2022 7:58 PM EST100$1.75
Jun 13, 2022 7:58 PM EST14$1.74
Jun 13, 2022 7:59 PM EST66$1.75
Jun 13, 2022 7:59 PM EST100$1.745

CytomX Therapeutics, Inc (CTMX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312520176532/0001193125-20-176532-index.htm
2020-04-29UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1501989/000000000020003688/0000000000-20-003688-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501989/000008025519002692/0000080255-19-002692-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501989/000008025520001289/0000080255-20-001289-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501989/000021545719003156/0000215457-19-003156-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501989/000031506619000973/0000315066-19-000973-index.htm
2019-04-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501989/000031506619001491/0000315066-19-001491-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501989/000083423720005271/0000834237-20-005271-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501989/000090221919000110/0000902219-19-000110-index.htm
2020-01-27SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501989/000090221920000074/0000902219-20-000074-index.htm
2020-03-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501989/000092189520000679/0000921895-20-000679-index.htm
2020-01-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501989/000104018820000077/0001040188-20-000077-index.htm
2020-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501989/000110465920016389/0001104659-20-016389-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000114036118031328/0001140361-18-031328-index.htm
2018-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000114036118031810/0001140361-18-031810-index.htm
2018-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000114036118031945/0001140361-18-031945-index.htm
2018-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000114036118035277/0001140361-18-035277-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1501989/000114036119007688/0001140361-19-007688-index.htm
2019-04-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501989/000114036119007690/0001140361-19-007690-index.htm
2020-04-17PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1501989/000114036120009192/0001140361-20-009192-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1501989/000114036120010142/0001140361-20-010142-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1501989/000114036120010147/0001140361-20-010147-index.htm
2018-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312518215419/0001193125-18-215419-index.htm
2018-07-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501989/000119312518215425/0001193125-18-215425-index.htm
2018-07-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501989/000119312518217946/0001193125-18-217946-index.htm
2018-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312518219686/0001193125-18-219686-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312518353898/0001193125-18-353898-index.htm
2019-01-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312519023949/0001193125-19-023949-index.htm
2019-02-06S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1501989/000119312519029601/0001193125-19-029601-index.htm
2019-02-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1501989/000119312519032241/0001193125-19-032241-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501989/000119312519037944/0001193125-19-037944-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501989/000119312519040972/0001193125-19-040972-index.htm
2019-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501989/000119312519054171/0001193125-19-054171-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312519085264/0001193125-19-085264-index.htm
2019-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312519100706/0001193125-19-100706-index.htm
2019-04-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312519113391/0001193125-19-113391-index.htm
2019-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312519158784/0001193125-19-158784-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312519178790/0001193125-19-178790-index.htm
2019-06-218-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312519178811/0001193125-19-178811-index.htm
2019-08-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312519226958/0001193125-19-226958-index.htm
2019-08-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312519234035/0001193125-19-234035-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1501989/000119312520038279/0001193125-20-038279-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312520043696/0001193125-20-043696-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1501989/000119312520052872/0001193125-20-052872-index.htm
2020-02-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1501989/000119312520053023/0001193125-20-053023-index.htm
2020-03-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312520082679/0001193125-20-082679-index.htm
2020-03-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312520083210/0001193125-20-083210-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312520090977/0001193125-20-090977-index.htm
2020-04-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1501989/000119312520122043/0001193125-20-122043-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312520123071/0001193125-20-123071-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312520155943/0001193125-20-155943-index.htm
2020-06-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312520176532/0001193125-20-176532-index.htm
2020-10-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000119312520264740/0001193125-20-264740-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501989/000156459018020448/0001564590-18-020448-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000156459018020463/0001564590-18-020463-index.htm
2018-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000156459018024564/0001564590-18-024564-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501989/000156459018027387/0001564590-18-027387-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000156459018027403/0001564590-18-027403-index.htm
2018-11-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1501989/000156459018027415/0001564590-18-027415-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000156459019004252/0001564590-19-004252-index.htm
2019-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1501989/000156459019004890/0001564590-19-004890-index.htm
2019-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000156459019004900/0001564590-19-004900-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501989/000156459019017968/0001564590-19-017968-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000156459019017981/0001564590-19-017981-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501989/000156459019030054/0001564590-19-030054-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000156459019030064/0001564590-19-030064-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501989/000156459019041726/0001564590-19-041726-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000156459019041743/0001564590-19-041743-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1501989/000156459020007395/0001564590-20-007395-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000156459020007430/0001564590-20-007430-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501989/000156459020022844/0001564590-20-022844-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000156459020022870/0001564590-20-022870-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501989/000156459020037722/0001564590-20-037722-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000156459020037749/0001564590-20-037749-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1501989/000156459020051302/0001564590-20-051302-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1501989/000156459020051317/0001564590-20-051317-index.htm
2018-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761918002231/0001567619-18-002231-index.htm
2018-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761918002232/0001567619-18-002232-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761918003477/0001567619-18-003477-index.htm
2018-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761918005081/0001567619-18-005081-index.htm
2018-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761918005082/0001567619-18-005082-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761918007414/0001567619-18-007414-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761918007415/0001567619-18-007415-index.htm
2018-12-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761918008005/0001567619-18-008005-index.htm
2018-12-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761918008730/0001567619-18-008730-index.htm
2018-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761918008731/0001567619-18-008731-index.htm
2019-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919001862/0001567619-19-001862-index.htm
2019-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919001863/0001567619-19-001863-index.htm
2019-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919001864/0001567619-19-001864-index.htm
2019-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919001865/0001567619-19-001865-index.htm
2019-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919001866/0001567619-19-001866-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919006113/0001567619-19-006113-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919008682/0001567619-19-008682-index.htm
2019-05-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919009690/0001567619-19-009690-index.htm
2019-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919009691/0001567619-19-009691-index.htm
2019-05-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919010365/0001567619-19-010365-index.htm
2019-05-313Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919012520/0001567619-19-012520-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919012666/0001567619-19-012666-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919012669/0001567619-19-012669-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919012671/0001567619-19-012671-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919013822/0001567619-19-013822-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919013823/0001567619-19-013823-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919013824/0001567619-19-013824-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919013825/0001567619-19-013825-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919013826/0001567619-19-013826-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919013827/0001567619-19-013827-index.htm
2019-10-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919019674/0001567619-19-019674-index.htm
2019-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919019675/0001567619-19-019675-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761919023150/0001567619-19-023150-index.htm
2020-02-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920002229/0001567619-20-002229-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920002230/0001567619-20-002230-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920004345/0001567619-20-004345-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920004346/0001567619-20-004346-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920004347/0001567619-20-004347-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920004348/0001567619-20-004348-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920004554/0001567619-20-004554-index.htm
2020-03-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920006995/0001567619-20-006995-index.htm
2020-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920006996/0001567619-20-006996-index.htm
2020-04-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920008616/0001567619-20-008616-index.htm
2020-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920008617/0001567619-20-008617-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920010115/0001567619-20-010115-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920011542/0001567619-20-011542-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920012298/0001567619-20-012298-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920012299/0001567619-20-012299-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920012300/0001567619-20-012300-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920012301/0001567619-20-012301-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920012304/0001567619-20-012304-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920012361/0001567619-20-012361-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920012433/0001567619-20-012433-index.htm
2020-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1501989/000156761920017051/0001567619-20-017051-index.htm
2019-02-11EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1501989/999999999519000158/9999999995-19-000158-index.htm
2018-11-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1501989/999999999718009035/9999999997-18-009035-index.htm
2018-11-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1501989/999999999718009038/9999999997-18-009038-index.htm

CytomX Therapeutics, Inc (CTMX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of CytomX Therapeutics, Inc (CTMX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 289%
Institutional Ownership: 8350%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-09-21Sean A. McCarthyPresident and CEOBuy20,500.006.61135,601.35105,964.00https://www.sec.gov/Archives/edgar/data/1501989/000156761920017051/0001567619-20-017051-index.htm
2019-05-31LLOYD A ROWLANDGeneral CounselBuy1,812.008.2114,878.3311,791.00https://www.sec.gov/Archives/edgar/data/1501989/000156761919012671/0001567619-19-012671-index.htm
2020-05-12Sean A. McCarthyPresident and CEOBuy36,000.001.1340,820.40120,306.00https://www.sec.gov/Archives/edgar/data/1501989/000156761920010115/0001567619-20-010115-index.htm
2019-05-31Robin KnifsendPrincipal Accounting OfficerBuy1,812.008.2114,878.332,791.00https://www.sec.gov/Archives/edgar/data/1501989/000156761919012669/0001567619-19-012669-index.htm
2018-07-02DEBANJAN RAYChief Financial OfficerSell3,000.0022.5667,680.005,928.00https://www.sec.gov/Archives/edgar/data/1501989/000114036118031328/0001140361-18-031328-index.htm
2018-08-01DEBANJAN RAYChief Financial OfficerSell3,000.0026.0578,150.005,928.00https://www.sec.gov/Archives/edgar/data/1501989/000114036118035277/0001140361-18-035277-index.htm
2018-09-04DEBANJAN RAYChief Financial OfficerSell3,000.0022.3967,170.005,928.00https://www.sec.gov/Archives/edgar/data/1501989/000156761918002232/0001567619-18-002232-index.htm
2018-10-01DEBANJAN RAYChief Financial OfficerSell3,000.0018.4655,380.005,928.00https://www.sec.gov/Archives/edgar/data/1501989/000156761918003477/0001567619-18-003477-index.htm
2018-11-01DEBANJAN RAYChief Financial OfficerSell3,000.0015.0045,000.005,928.00https://www.sec.gov/Archives/edgar/data/1501989/000156761918005082/0001567619-18-005082-index.htm
2018-12-12DEBANJAN RAYChief Financial OfficerSell3,000.0015.0045,000.005,928.00https://www.sec.gov/Archives/edgar/data/1501989/000156761918008005/0001567619-18-008005-index.htm
2018-07-03Sean A. McCarthyPresident and CEOSell2,028.0025.0950,880.4982,063.00https://www.sec.gov/Archives/edgar/data/1501989/000114036118031810/0001140361-18-031810-index.htm
2018-07-05Sean A. McCarthyPresident and CEOSell4,497.0025.06112,688.5282,063.00https://www.sec.gov/Archives/edgar/data/1501989/000114036118031945/0001140361-18-031945-index.htm
2018-09-04Sean A. McCarthyPresident and CEOSell13,052.0021.86285,342.8282,063.00https://www.sec.gov/Archives/edgar/data/1501989/000156761918002231/0001567619-18-002231-index.htm
2018-11-01Sean A. McCarthyPresident and CEOSell5,270.0015.0079,050.0082,063.00https://www.sec.gov/Archives/edgar/data/1501989/000156761918005081/0001567619-18-005081-index.htm
2018-11-02Sean A. McCarthyPresident and CEOSell1,156.0015.0117,348.0982,063.00https://www.sec.gov/Archives/edgar/data/1501989/000156761918005081/0001567619-18-005081-index.htm
2018-11-30Sean A. McCarthyPresident and CEOBuy468.0011.735,489.6482,531.00https://www.sec.gov/Archives/edgar/data/1501989/000156761918007415/0001567619-18-007415-index.htm
2018-11-02Sean A. McCarthyPresident and CEOBuy1,156.001.571,820.5883,219.00https://www.sec.gov/Archives/edgar/data/1501989/000156761918005081/0001567619-18-005081-index.htm
2019-05-31Sean A. McCarthyPresident and CEOBuy695.008.215,706.6583,226.00https://www.sec.gov/Archives/edgar/data/1501989/000156761919012666/0001567619-19-012666-index.htm
2018-07-03Sean A. McCarthyPresident and CEOBuy2,028.001.573,193.9084,091.00https://www.sec.gov/Archives/edgar/data/1501989/000114036118031810/0001140361-18-031810-index.htm
2019-11-30Sean A. McCarthyPresident and CEOBuy1,080.005.325,746.6884,306.00https://www.sec.gov/Archives/edgar/data/1501989/000156761919023150/0001567619-19-023150-index.htm
2020-05-12Sean A. McCarthyPresident and CEOSell36,000.0015.00540,000.0084,306.00https://www.sec.gov/Archives/edgar/data/1501989/000156761920010115/0001567619-20-010115-index.htm
2020-05-29Sean A. McCarthyPresident and CEOBuy1,158.005.115,915.6485,464.00https://www.sec.gov/Archives/edgar/data/1501989/000156761920011542/0001567619-20-011542-index.htm
2018-08-01DEBANJAN RAYChief Financial OfficerBuy2,710.001.263,414.338,638.00https://www.sec.gov/Archives/edgar/data/1501989/000114036118035277/0001140361-18-035277-index.htm
2018-07-05Sean A. McCarthyPresident and CEOBuy4,497.001.577,082.3386,560.00https://www.sec.gov/Archives/edgar/data/1501989/000114036118031945/0001140361-18-031945-index.htm
2018-11-01Sean A. McCarthyPresident and CEOSell100.0015.011,500.5087,333.00https://www.sec.gov/Archives/edgar/data/1501989/000156761918005081/0001567619-18-005081-index.htm
2018-11-01Sean A. McCarthyPresident and CEOBuy5,370.001.578,457.2187,433.00https://www.sec.gov/Archives/edgar/data/1501989/000156761918005081/0001567619-18-005081-index.htm
2018-07-02DEBANJAN RAYChief Financial OfficerBuy3,000.001.263,779.708,928.00https://www.sec.gov/Archives/edgar/data/1501989/000114036118031328/0001140361-18-031328-index.htm
2018-08-01DEBANJAN RAYChief Financial OfficerBuy290.001.45420.188,928.00https://www.sec.gov/Archives/edgar/data/1501989/000114036118035277/0001140361-18-035277-index.htm
2018-09-04DEBANJAN RAYChief Financial OfficerBuy3,000.001.454,346.708,928.00https://www.sec.gov/Archives/edgar/data/1501989/000156761918002232/0001567619-18-002232-index.htm
2018-10-01DEBANJAN RAYChief Financial OfficerBuy3,000.001.454,346.708,928.00https://www.sec.gov/Archives/edgar/data/1501989/000156761918003477/0001567619-18-003477-index.htm
2018-11-01DEBANJAN RAYChief Financial OfficerBuy3,000.001.454,346.708,928.00https://www.sec.gov/Archives/edgar/data/1501989/000156761918005082/0001567619-18-005082-index.htm
2018-12-12DEBANJAN RAYChief Financial OfficerBuy3,000.001.454,346.708,928.00https://www.sec.gov/Archives/edgar/data/1501989/000156761918008005/0001567619-18-008005-index.htm
2018-09-04Sean A. McCarthyPresident and CEOBuy13,052.001.5720,555.5995,115.00https://www.sec.gov/Archives/edgar/data/1501989/000156761918002231/0001567619-18-002231-index.htm
2018-11-30LLOYD A ROWLANDGeneral CounselBuy979.0011.7311,483.67979.00https://www.sec.gov/Archives/edgar/data/1501989/000156761918007414/0001567619-18-007414-index.htm
2019-03-04LLOYD A ROWLANDGeneral CounselBuy9,000.0010.3392,970.009,979.00https://www.sec.gov/Archives/edgar/data/1501989/000156761919006113/0001567619-19-006113-index.htm